Inflammation and atherosclerosis in end-stage renal disease.
about
Clinical nutrition scores are superior for the prognosis of haemodialysis patients compared to lab markers and bioelectrical impedance.The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan.Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis.Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1Protecting the endothelium: a new focus for management of chronic kidney disease.Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol - Differences or Similarities?Association of E-selectin with hematological, hormonal levels and plasma proteins in children with end stage renal disease.Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndromeStatins, inflammation and kidney disease.Hibiscus sabdariffa Linnaeus aqueous extracts attenuate the progression of renal injury in 5/6 nephrectomy rats.Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive miceNitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation.Association of E-selectin gene polymorphism and serum PAPP-A with carotid atherosclerosis in end-stage renal disease.Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients.Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.Elevated plasma levels of PAI-1 predict cardiovascular events and cardiovascular mortality in prevalent peritoneal dialysis patients.Circulating E-selectin as a risk marker in patients with end-stage renal disease.Beneficial effect of statins in patients receiving chronic hemodialysis following percutaneous coronary intervention: A nationwide retrospective cohort study.Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based studyUpdating the lipids hypothesis of inflammation and vascular disease in patients with chronic kidney disease: a stearoyl-CoA desaturase affair?
P2860
Q30319057-75E8DB6E-7F6D-410C-966A-030123939659Q34366134-3503E1A0-AF27-43EE-A57F-672D5A839911Q36293944-0A72A864-1178-47E9-9C40-1630D59BD303Q36379017-571609FD-7033-469C-A84E-1E0DE283FBFDQ36379593-C75A08AA-A035-4ACF-B58B-E3D7821A4DBDQ37041316-8D522CB4-6E9E-4C1D-8CAC-587AC74C04D0Q37157840-0E5136BE-04EE-4F81-80C1-749D4410E0FCQ37324434-C4C603C7-D6AB-4951-839D-BE734E8640C3Q37831838-68D04265-853A-4C64-8C1A-A6760B622133Q37883015-5AC03726-39FE-44BE-83D3-E44C51C254E0Q39447854-0CEB09DD-5793-410F-A951-6BABB7F7E6B2Q41549740-8A2F1170-9BDC-4A7C-AF3E-51C07B2058A6Q42770237-4FD155D9-2EF5-4647-842E-7B79C94488FCQ46429830-DDA333CB-1EFD-4DC2-8045-4DB59734CEF1Q50787029-6A7DD14D-EFB2-41F8-BFEF-F3BDD87A3CEDQ51065329-543F6899-BE19-4C8A-BCED-BC7A5C89E39BQ51608697-475DE6A6-7421-4561-8F04-DA1562E6DECBQ53527306-7257F6BE-9492-42B7-8765-56160AD85B86Q55512228-1BF8CE9A-4B23-43A8-AB3A-5DA5BFC3F51CQ57813255-8F204C0A-8D08-4764-9576-A0B80FEFA602Q58946477-8B1FA6AD-1589-4500-B7D7-B29819584A08
P2860
Inflammation and atherosclerosis in end-stage renal disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inflammation and atherosclerosis in end-stage renal disease.
@ast
Inflammation and atherosclerosis in end-stage renal disease.
@en
type
label
Inflammation and atherosclerosis in end-stage renal disease.
@ast
Inflammation and atherosclerosis in end-stage renal disease.
@en
prefLabel
Inflammation and atherosclerosis in end-stage renal disease.
@ast
Inflammation and atherosclerosis in end-stage renal disease.
@en
P356
P1433
P1476
Inflammation and atherosclerosis in end-stage renal disease.
@en
P2093
Francesca Mallamaci
Giovanni Tripepi
P356
10.1159/000067852
P577
2003-01-01T00:00:00Z